For the Inventor, By the Inventor

Enter inventor name

Atherton, CA, United States of America

Michael T Longaker

USPTO Granted Patents = 26 (Patent Applications = 17)

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 5 (Patent Applications = 10)

Average Co-Inventor Count = 4.5

ph-index = 9

Forward Citations = 312(Granted Patents)

Location History:

Stanford, CA (US) (2015 - 2017)
Atherton, CA (US) (2010 - 2023)

Company Filing History:

22 out of 5,309

Leland Stanford Junior University

Neodyne Biosciences, Inc.

Years Active: 2010-2025

Loading Chart...

Loading Chart...

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12403106 - Prophylactic skin treatment for radiation therapy (2025-09-02),

2. 12303475 - Conditioning irradiated tissue for increasing vascularity (2025-05-20),

3. 12236599 - Systems and methods for analyzing, detecting, and treating fibrotic connective tissue network formation (2025-02-25),

4. 11701262 - Devices and methods for skin tightening (2023-07-18),

5. 11529391 - Reversing deficient hedgehog signaling restores deficient skeletal regeneration (2022-12-20),

6. 11369641 - Identification and uses of vasculature forming progenitor cells and progenitor cell combinations (2022-06-28),

7. 11331288 - Conditioning irradiated tissue for increasing vascularity (2022-05-17),

8. 11246763 - Skin treatment devices and methods with pre-stressed configurations (2022-02-15),

9. 11083755 - Factors and cells that provide for induction of bone, bone marrow, and cartilage (2021-08-10),

10. 10857037 - Controlled strain skin treatment devices and methods (2020-12-08),

11. 10561359 - Elastic devices, methods, systems and kits for selecting skin treatment devices (2020-02-18),

12. 9889046 - Skin treatment devices and methods with pre-stressed configurations (2018-02-13),

13. 9827447 - Devices, methods, systems and kits for selecting skin treatment devices (2017-11-28),

14. 9655967 - Inhibition of focal adhesion kinase for control of scar tissue formation (2017-05-23),

15. 9395354 - Cardiomyocytes from induced pluripotent stem cells from patients and methods of use thereof (2016-07-19),

Title: Inventor Michael T. Longaker - Pioneering Innovations in Medicine

Introduction: Michael T. Longaker is a distinguished inventor known for his groundbreaking contributions to the field of medicine, particularly in the realm of regenerative medicine and tissue engineering.

Latest Patents: Michael T. Longaker holds several patents related to novel surgical techniques, advanced wound healing technologies, and innovative approaches to tissue regeneration.

Career Highlights: With a career spanning several decades, Michael T. Longaker has held prominent positions at renowned research institutions and universities, where he has led pioneering research projects and mentored numerous aspiring scientists.

Collaborations: Throughout his career, Michael T. Longaker has collaborated with leading experts in various disciplines, fostering a culture of innovation and interdisciplinary research that has resulted in significant advancements in the field of medicine.

Conclusion: Michael T. Longaker's relentless pursuit of innovation and his commitment to pushing the boundaries of medical science have solidified his reputation as a visionary inventor whose work continues to inspire and shape the future of regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…